INFECTION PREVENTION & WOUNDCARE
Jane Clark, marketing manager UK & Ireland of Systagenix, explains more about the confirmation from a post- launch focus group1
flow of exudate to the secondary dressing and causes minimal or no trauma on removal.
where a relatively quick dressing change can reduce emotional distress for the child and parent. It was also noted that for nurses working in the community where access to the wound can be challenging and they may be working against gravity, e.g. back of a leg when the patient is seated, the dressing stayed in place on initial application allow- ing time to apply the secondary dressing.
One participant noted that when Adaptic Touch was used under a topical negative pressure (TNP) device, there were less ob- servable buds of granulation tissue coming through the dressing than with some other similar products. This positive feature was attributed to the size of the pores in the dressing.
A
daptic Touch silicone dressing is a non-adherent, flexible, open-mesh
primary wound contact layer composed of cellulose acetate coated with a soft tack silicone. It is designed to stay in place un- assisted during dressing application, also to allow exudate to pass into an absorbent secondary dressing and to be atraumatic with regard to both the wound and sur- rounding skin during dressing change. The non-adherent nature of the dressing also helps to reduce pain during dress- ing change. A similar soft silicone coating is found on Adaptic Digit Non-Adhering Dressing, a dressing designed for finger and toe injuries.
In spring 2011, a multidisciplinary group of clinicians formed a post-launch focus group to discuss their experiences of using Adap- tic Touch non-adherent silicone primary contact layer in clinical practice. The infor-
60 | national health executive Sep/Oct 11
mation gained adds to the research already available on the product, which has been presented in various formats including a re- view by Bianchi and Gray. 2
The in vivo evi-
dence, along with pre-launch focus groups and case reports, indicated that the product performed well in both laboratory and clini- cal settings. The post-launch focus group discussed properties such as initial tack on application, ease of application and removal, atraumatic dressing changes and cost-effec- tiveness, offering an invaluable insight into how the product functions in practice.
Initial application on the wound, ease of use and removal and exudate manage- ment, were highlighted as being positive aspects of the dressing by the focus group.
The group found that the dressing had advantages over other similar products, particularly when working with children
Cost-savings, compared to other simi- lar products, was also a key factor. One of the participants has changed from a more expensive product to Adaptic Touch, with predicted cost-savings to the trust of £40,000.
The authors conclude that the dressing performed well when applied to different wound types, in a variety of clinical set- tings, such as primary and secondary care, and within secondary care paediatrics, burn units and minor injury departments. In clinical situations the product was rated as being as good as, or better than similar products and its cost-effectiveness was highlighted as an important factor.
References 1. Bianchi, J. et al. Consensus guidance for the use of Adaptic Touchnon-adherent dressing. Wounds uk, 2011, Vol 7, No 3. 2. Bianchi, J. and Gray, D. Adaptic Touchnon-adherent dressing, Wounds UK Journal, 2011. vol. 7 (1).
FOR MORE INFORMATION
Jane Clark T: 07778 333 521 E:
jane.clark@
systagenix.com W:
www.systagenix.co.uk
that the Adaptic Touch product is clinically effective with regard to ease of application, free
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104